APOA1 antibody (HRP)
Quick Overview for APOA1 antibody (HRP) (ABIN7449327)
Target
See all APOA1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- Goat anti-Human Apo AI [H03] Antibody HRP Conjugated
-
Immunogen
- Human Apolipoprotein AI
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB: 1:1,000 - 1:8,000
ELISA: 1:1,000 - 1:8,000
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- 50 mM PBS, 0.1 M NaCl, and 0.01 % Thiomersal, pH 7.4
-
Preservative
- Thimerosal (Merthiolate)
-
Precaution of Use
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Expiry Date
- 12 months
-
-
- APOA1 (Apolipoprotein A-I (APOA1))
-
Alternative Name
- ApoAI
-
Background
- Background: Apo AI comprises approximately 70 % of the protein moiety in HDL. It is a single polypeptide chain consisting of 243 amino acid residues without disulfide bound and with glutamic acid as the C-terminal residue and aspartic acid as the N-terminal residue. The molecular weight is reported to be 28 kDa (Brewer et al., 1978). The roles of Apo AI in HDL function include reverse cholesterol transportation, lipid cholesterol binding, lecithin-cholesterol acyl transferase (LCAT) activation, and receptor binding, which is responsible for cholesterol esterification in plasma. Besides participate in cholesterol metabolism, Apo AI and HDL also suppress neutrophil activation, inhibit bacterial endotoxin, induce trypanosomal lysis, and other physiological activities. (Brouillette et al., 2001). Apo AI levels may be inversely related to the risk of coronary disease. In previous research, Apo AI may affect diet-induced inflammation by either directly or indirectly altering lipid rafts. (Cheng et al., 2012)
-
Gene ID
- 335
-
NCBI Accession
- NP_000030
-
UniProt
- P02647
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Lipid Metabolism
Target
-